U.S. Hotel and Resort REITs Stock News

NYSE:VAC
NYSE:VACHospitality

Did a New Sales Chief and Counsel Exit Just Shift Marriott Vacations Worldwide's (VAC) Investment Narrative?

Marriott Vacations Worldwide recently reshaped its leadership team, appointing industry veteran Tony Walker as Executive Vice President and Chief Sales and Marketing Officer while long-serving General Counsel James Hunter stepped down ahead of his planned retirement. This leadership transition brings in deep timeshare and experience-based sales expertise at a moment when the company is working through weak demand, competition, and operational challenges highlighted by recent analyst...
NYSE:MOH
NYSE:MOHHealthcare

Is Molina Healthcare (MOH) Offering Opportunity After Medicaid Contract Concerns And Strong DCF Upside

Wondering if Molina Healthcare at around US$143.96 is a bargain or a value trap? This article focuses squarely on what the current price actually says about the stock. The share price has moved 1.9% over the last week and 6.4% over the last month, but the year-to-date return of 19.3% and 1-year return of 54.6% decline give a very different context to where the stock sits today. Recent news coverage has centered on Molina Healthcare's position in the managed care space, including commentary...
NasdaqGS:AUR
NasdaqGS:AURSoftware

Aurora’s Board Shakeup and Driverless Milestones Could Be A Game Changer For Aurora Innovation (AUR)

Aurora Innovation recently added Meta’s chief strategy officer and former chief financial officer David Wehner to its board, replacing Claire Hughes Johnson, while reporting progress toward breakeven gross margins by the end of 2026 and positive free cash flow by 2028. The company has now logged more than 4.5 million autonomous miles, including over 250,000 fully driverless miles, and plans to scale its driverless truck fleet from 10 at the end of 2025 to more than 200 trucks, supported by...
NYSE:SMR
NYSE:SMRElectrical

Does NuScale Power (SMR) Share Price Still Match Its Long Term Nuclear Story?

Wondering whether NuScale Power's current share price still reflects the story you have in mind, or if the stock is now pricing in a very different future. NuScale shares recently closed at US$12.44, with returns of 3.4% over 7 days but a 13.1% decline over 30 days and a 23.7% decline year to date, alongside a 25.0% decline over the last year and gains of 40.4% over 3 years and 25.9% over 5 years. These mixed returns sit against a backdrop of ongoing attention on nuclear energy...
NYSE:CARR
NYSE:CARRBuilding

Carrier Global Backs Heat Geek To Tap European Heat Pump Growth

Carrier Global Ventures, the venture arm of NYSE:CARR, has invested in UK-based residential heat pump platform Heat Geek. The partnership is aimed at accelerating residential heat pump adoption across Europe. The move expands Carrier's presence in electrified heating and digital solutions for homeowners. For you as an investor, this connects directly to Carrier's core role in heating, ventilation and air conditioning, as well as its focus on climate technologies. Heat pumps are an important...
NYSE:GPC
NYSE:GPCRetail Distributors

Is Genuine Parts (GPC) Offering Value After The Recent 30% Share Price Slide

Wondering if Genuine Parts at around US$102.82 is offering real value right now, or if the recent share price moves are a warning sign you should pay attention to. Over the last week the stock has seen a 5.6% decline, with a 30.1% decline over 30 days and a 17.1% decline year to date, set against a 14.3% decline over 1 year and a modest 2.9% gain across 5 years. These moves sit against a backdrop where investors are reassessing auto and industrial parts distributors in general, focusing more...
NasdaqGM:SMMT
NasdaqGM:SMMTBiotechs

Assessing Summit Therapeutics (SMMT) Valuation After Jefferies Downgrade And Mixed Quarter

Summit Therapeutics (SMMT) is back in focus after a Jefferies downgrade to Hold, tied to risks around four major 2026 clinical catalysts and a mixed fourth quarter 2025 earnings update. See our latest analysis for Summit Therapeutics. The Jefferies downgrade and mixed fourth quarter 2025 earnings update come after a year where the share price return is weak year to date at a 9.53% decline, despite a very large three year total shareholder return that indicates earlier buyers have already seen...
NasdaqGS:XP
NasdaqGS:XPCapital Markets

Is It Time To Revisit XP (XP) After Recent Share Price Pullback?

If you are wondering whether XP at US$19.03 still offers value or if the easy gains are behind it, the key is to look closely at what the current price actually implies. The stock has had mixed recent moves, with a 5.5% decline over the last 7 days and a 4.2% decline over the last 30 days, set against a 17.6% return year to date and 25.9% over the past year. These swings sit on top of a longer record that includes an 81.2% return over 3 years and a 44.7% decline over 5 years. This history...
NYSE:HE
NYSE:HEElectric Utilities

Is Hawaiian Electric Industries (HE) Attractive After Recent Rebound And Ongoing Regulatory Headlines

With Hawaiian Electric Industries trading at around US$14.49, this article explores whether the stock might represent a bargain or a value trap by walking through key aspects of the current valuation. The stock has returned 14.7% year to date and 31.6% over the last year, while 3 year and 5 year returns show declines of 60.5% and 62.1%. This contrast may leave you considering how to weigh recent momentum against longer term performance. Recent headlines around Hawaiian Electric Industries...
NasdaqGS:EA
NasdaqGS:EAEntertainment

Assessing Electronic Arts (EA) Valuation After A Period Of Steady Long Term Shareholder Returns

Electronic Arts stock snapshot after recent performance Electronic Arts (EA) shares recently closed at US$200.13, with a 1 day return close to flat and modest moves over the past week, month, and past 3 months that frame a relatively muted short term performance profile. See our latest analysis for Electronic Arts. While the short term share price return has been slightly negative year to date, the 1 year total shareholder return of 41.67% and 3 year total shareholder return of 76.82% point...
NasdaqCM:VFF
NasdaqCM:VFFFood

A Look At Village Farms International’s Valuation As Profitability Follows Higher Quarterly And Annual Sales

Why the latest earnings and buyback matter for Village Farms International (VFF) Village Farms International (NasdaqCM:VFF) has drawn fresh attention after reporting fourth quarter and full year 2025 results that show net income for both periods, alongside completion of a US$2.98 million share repurchase program. See our latest analysis for Village Farms International. Despite turning net income positive for both the quarter and full year and completing the US$2.98 million buyback, Village...
NYSE:MTB
NYSE:MTBBanks

M&T Bank Technology And Talent Push Versus Valuation Discount And Risks

M&T Bank (NYSE:MTB) CEO releases an annual letter highlighting investments in technology and talent as key priorities. The letter links these investments to the bank’s recent performance and outlines how they fit into long term plans. Management stresses a sustained focus on digital capabilities, data, and workforce development in a choppy economic climate. M&T Bank is a regional banking group with a focus on traditional lending, deposits, and related financial services, and it operates in...
NasdaqGS:FROG
NasdaqGS:FROGSoftware

Is JFrog (FROG) Priced Right After Strong Multi Year Share Price Performance

If you are wondering whether JFrog's current share price reflects its true worth, this breakdown will help you connect the recent numbers to what you are actually paying for the stock. At a last close of US$43.83, JFrog has returned 7.1% over the past week, while the 30 day and year to date returns of 15.2% and 26.4% respectively contrast with a 29.2% return over the past year and 127.7% over three years. Recent headlines have focused broadly on the software sector and investor interest in...
NasdaqGS:ASND
NasdaqGS:ASNDBiotechs

Is It Time To Reassess Ascendis Pharma (ASND) After Its 38% One-Year Surge?

Wondering if Ascendis Pharma at around US$228.06 per share still offers value or if the easy gains are behind it? This article focuses squarely on what the current price might imply about future expectations. The stock has been volatile recently, with a 5.2% decline over the last week, a 5.4% gain over the past month, and returns of 6.9% year to date and 38.5% over the last year. These shifts can change how you think about both opportunity and risk. These moves sit against a backdrop of...
NYSE:IOT
NYSE:IOTSoftware

Profit Turn, AI Safety Upgrades, and Share Shelf Might Change The Case For Investing In Samsara (IOT)

Earlier in March 2026, Samsara Inc. reported fourth-quarter revenue of US$444.3 million and full-year revenue of US$1.62 billion, turning a quarterly profit while nearly eliminating its annual net loss, and soon after filed a US$1.11 billion shelf registration for 34,842,934 Class A shares tied to employee stock programs. Around the same time, the company introduced new AI-driven coaching features for its fleet safety platform and secured a US$30.3 million arbitration award, changes that...
NYSE:TXT
NYSE:TXTAerospace & Defense

The Bull Case For Textron (TXT) Could Change Following New Global Public-Safety Helicopter Orders – Learn Why

Textron’s Bell unit recently secured orders from South Africa’s National Transmission Company for seven Bell 407GX helicopters and from the Pasadena Police Department for two Bell 505 helicopters, all designated for utility and public safety missions. These contracts highlight how Textron is extending the reach of its helicopter portfolio into both international infrastructure work and specialized municipal law‑enforcement operations. Next, we’ll examine how these new helicopter orders,...
NYSE:FCN
NYSE:FCNProfessional Services

A Look At FTI Consulting (FCN) Valuation As Recent Returns Show Mixed Momentum

FTI Consulting (FCN) has been drawing attention after recent share price moves, with the stock last closing at US$163.42. Investors are weighing this performance against its earnings profile and multi segment advisory business. See our latest analysis for FTI Consulting. The recent 1 day share price return of 0.93% and 7 day share price return of 0.65% sit against a 90 day share price return of 7.52% and a 1 year total shareholder return of 1.90%. This suggests momentum has cooled after...
NYSE:AVTR
NYSE:AVTRLife Sciences

Eversept Ups Avantor Stake As Revival Program And Valuation Draw Focus

Eversept Partners has made a significant institutional investment in Avantor (NYSE:AVTR), increasing its ownership stake in the company. The move comes as Avantor presses ahead with its Revival program, which is aimed at responding to prolonged organic revenue declines and restructuring efforts. These ownership changes and internal initiatives are drawing fresh attention to Avantor's potential direction and risk profile. Avantor supplies products and services to the life sciences and...
NasdaqGM:PAHC
NasdaqGM:PAHCPharmaceuticals

Phibro Insider Moves Shift Class Structure As Stock Trades Near Highs

Director Jack Bendheim has sold a significant amount of NasdaqGM:PAHC stock under a pre arranged trading plan. BFI Co., LLC has converted 100,000 shares of Phibro Animal Health Class B Common Stock into Class A Common Stock. The transactions affect insider holdings, voting rights, and the mix between Class A and Class B shares in the company’s capital structure. Phibro Animal Health, listed on NasdaqGM:PAHC, focuses on animal health and nutrition products that support livestock producers...
NYSE:HEI
NYSE:HEIAerospace & Defense

Is It Too Late To Consider HEICO (HEI) After The Recent Share Price Pullback?

Wondering if HEICO at around US$292.21 is still offering value, or if the best days are already priced in? This article focuses squarely on what you are paying versus what you might be getting. The share price sits near US$292.21 after a 4.6% decline over the past week and 12.1% over the last month, yet the stock has returned 12.1% over 1 year, 74.6% over 3 years and 140.9% over 5 years. Recent coverage has focused on HEICO as a key aerospace and defense name, with investors watching how...
NYSE:TNK
NYSE:TNKOil and Gas

Is Teekay Tankers’ (TNK) Zero‑Debt, Sanctions‑Exposed Model Reshaping Its Long‑Term Risk Profile?

Teekay Tankers recently reported strong 2025 operational and financial results, highlighting a zero‑debt balance sheet and significant free cash flow supported by a robust spot tanker market shaped by geopolitical tensions and sanctions-related trade shifts. The company’s gradual fleet renewal, focused on selective vessel acquisitions and sales while benefiting from heightened demand for compliant tankers, underscores how sanctions on Russian, Iranian, and Venezuelan oil are structurally...
NYSE:CFG
NYSE:CFGBanks

How Analyst Upgrades and San Francisco Commitments Could Reshape Citizens Financial Group’s (CFG) Investment Narrative

Earlier in March 2026, Citizens Financial Group received multiple analyst upgrades highlighting its loan growth, net interest margin expansion, and strong capital return, while simultaneously announcing new community and economic investment commitments in San Francisco, including US$250,000 for the San Francisco Downtown Development Corporation and US$500,000 for Main Street Launch. Together, these endorsements and local investments highlight Citizens’ attempt to pair national financial...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

Nuvation Bio Cancer Data Update Tests Valuation Gap After Share Pullback

Nuvation Bio (NYSE:NUVB) presented nearly one additional year of follow up data from the TRUST-I and TRUST-II studies of IBTROZI (taletrectinib) at the AACR Annual Meeting 2026. The new data focus on long term efficacy and safety in ROS1 positive non small cell lung cancer, including both treatment naïve and previously treated patients. This update builds on IBTROZI's existing FDA approval and adds fresh clinical detail that has not been reflected in recent coverage of the company. Nuvation...
NYSE:KR
NYSE:KRConsumer Retailing

Cold Case Rollout Tests Kroger’s Premium Ice Cream And Brand Strategy

Cold Case Ice Cream is expanding into more than 1,000 Kroger banner stores across the US. The rollout brings a trend-focused premium ice cream brand to a wide range of Kroger owned banners. The move underscores Kroger's focus on differentiated product assortments in the grocery aisle. For investors watching NYSE:KR, this large scale rollout highlights how Kroger is using branded partnerships to keep its frozen aisle fresh and relevant. The company operates a broad network of supermarket...